VICTORY! On June 13, 2013, the U.S. Supreme Court unanimously invalidated the patents on BRCA 1 and BRCA 2.
Kathleen Maxian has advanced-stage ovarian cancer that could have been prevented. When Myriad Genetics patented the two genes associated with breast and ovarian cancer they put Kathleen and thousands like her at risk.
A U.S. Court of Appeals has granted companies the right to patent genes, but the Supreme Court will hear arguments by the ACLU and the Public Patent Foundation on why patents on products of nature or laws of nature are illegal.